Latest Articles
GSK enters Indian oncology market with gynaecological cancer drugs - The New Indian Express
GSK enters Indian oncology market with gynaecological cancer drugs The New Indian Express
Published: Aug. 25, 2025, 8:44 a.m.
GSK enters into oncology segment; launches therapies for gynaecological cancers - newsdrum.in
GSK enters into oncology segment; launches therapies for gynaecological cancers newsdrum.in
Published: Aug. 25, 2025, 8 a.m.
Does This Patient Really Need a Gyn Oncology Referral? - Cleveland Clinic
Does This Patient Really Need a Gyn Oncology Referral? Cleveland Clinic
Published: Aug. 19, 2025, 4:55 a.m.
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight - The Malaysian Reserve
Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight The Malaysian Reserve
Published: Aug. 12, 2025, 10:20 p.m.
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in GlobeNewswire
Published: Aug. 6, 2025, 1:03 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central
First immunotherapy combination for endometrial cancer approved by NICE Oncology Central
Published: Aug. 6, 2025, 11:18 a.m.
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer Oncology Nursing News
Published: June 27, 2025, 6:10 p.m.
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - BioSpace
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting BioSpace
Published: May 23, 2025, 5:55 a.m.
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - The Manila Times
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting The Manila Times
Published: May 23, 2025, 12:24 a.m.
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting The Manila Times
Published: May 22, 2025, 9:19 p.m.
Link copied to clipboard!